Items where authors include "Lefley, D.V."
Article
Morita, M., Arshad, F., Quayle, L.A. et al. (8 more authors) (2024) Losartan alters osteoblast differentiation and increases bone mass through inhibition of TGFB signalling in vitro and in an OIM mouse model. Bone Reports, 22. 101795. ISSN 2352-1872
Zhou, J. orcid.org/0000-0003-1108-6391, Down, J.M., George, C.N. et al. (6 more authors) (2022) Novel methods of targeting IL-1 signalling for the treatment of breast cancer bone metastasis. Cancers, 14 (19). 4816.
Canuas-Landero, V.G., George, C.N., Lefley, D.V. et al. (4 more authors) (2021) Oestradiol contributes to differential antitumour effects of adjuvant zoledronic acid observed between pre- and post-menopausal women. Frontiers in Endocrinology, 12. 749428.
Tulotta, C., Lefley, D.V., Moore, C.K. et al. (13 more authors) (2021) IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer. npj Breast Cancer, 7 (1). 95.
Bishop, R.T., Marino, S., de Ridder, D. et al. (6 more authors) (2019) Pharmacological inhibition of the IKKε/TBK-1 axis potentiates the anti-tumour and anti-metastatic effects of Docetaxel in mouse models of breast cancer. Cancer Letters, 450. pp. 76-87. ISSN 0304-3835
Tulotta, C., Lefley, D.V., Freeman, K. et al. (16 more authors) (2019) Endogenous production of IL-1B by breast cancer cells drives metastasis and colonisation of the bone microenvironment. Clinical Cancer Research, 25 (9). pp. 2769-2782. ISSN 1078-0432
English, W.R. orcid.org/0000-0003-3024-2441, Lunt, S.J., Fisher, M. et al. (8 more authors) (2017) Differential expression of VEGFA isoforms regulates metastasis and response to anti-VEGFA therapy in sarcoma. Cancer Research, 77 (10). pp. 2633-2646. ISSN 0008-5472
Holen, I. orcid.org/0000-0002-8759-6913, Lefley, D.V., Francis, S.E. et al. (4 more authors) (2016) IL-1 drives breast cancer growth and bone metastasis in vivo. Oncotarget, 7. pp. 75571-75584. ISSN 1949-2553
Kanthou, C., Dachs, G.U., Lefley, D.V. et al. (8 more authors) (2014) Tumour Cells Expressing Single VEGF Isoforms Display Distinct Growth, Survival and Migration Characteristics. PLoS ONE, 9 (8). e104015. ISSN 1932-6203
Holen, I., Whitworth, J., Nutter, F. et al. (6 more authors) (2012) Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo. Breast Cancer Research, 14. R86 . ISSN 1465-5411
Conference or Workshop Item
Ottewell, P.D., Lefley, D.V., Coleman, R.E. et al. (1 more author) (2008) Mechanisms of apoptosis and cell-cycle arrest in subcutaneous breast tumours treated sequentially with doxorubicin followed by zoledronic acid. In: Breast Cancer Research 2008, 13 May 2008, London, UK.
Lefley, D.V., Holen, I., Coleman, R.E. et al. (1 more author) (2008) Pretreatment of breast cancer cells with doxorubicin facilitates the subsequent uptake of zoledronic acid. In: Breast Cancer Research 2008, May 2008, London, UK.